Myriad Genetics Inc.

(MYGN) Trade

By |

Profile

Myriad Genetics is a molecular diagnostics company that provides testing services designed to assess an individual's risk of developing a disease or tailor treatment for already diagnosed patients. The firm produces myRisk, a 28-gene panel with the capability to identify the elevated risk of developing eight types of cancer. Other diagnostic products include BRACAnalysis CDx, GeneSight, Vectra DA, and Prolaris. The firm also offers biomarker discovery and companion diagnostic services to pharmaceutical and biotechnology companies.

Contact Information

Website: www.myriad.com
Email: sgleason@myriad.com
Main Phone: +1 801 584-3600
Address: 320 Wakara Way
State: UT
City / Town: Salt Lake City
Country: USA
Postal Code: 84108

Issuer Information

Exchange: NGS
CEO: Mark Christopher Capone
Employees: 2600
NAICS: In-Vitro Diagnostic Substance Manufacturing(325413)

Equities News

View More

Profile

Myriad Genetics is a molecular diagnostics company that provides testing services designed to assess an individual's risk of developing a disease or tailor treatment for already diagnosed patients. The firm produces myRisk, a 28-gene panel with the capability to identify the elevated risk of developing eight types of cancer. Other diagnostic products include BRACAnalysis CDx, GeneSight, Vectra DA, and Prolaris. The firm also offers biomarker discovery and companion diagnostic services to pharmaceutical and biotechnology companies.

Contact Information

Website: www.myriad.com
Email: sgleason@myriad.com
Main Phone: +1 801 584-3600
Address: 320 Wakara Way
State: UT
City / Town: Salt Lake City
Country: USA
Postal Code: 84108

Issuer Information

Exchange: NGS
CEO: Mark Christopher Capone
Employees: 2600
NAICS: In-Vitro Diagnostic Substance Manufacturing(325413)

Equities News

View More
$ 19.65 $ -0.24 (-1.21%)
Last Price 19.65 Change $ -0.24 Change % -1.21 Tick N/A
Bid 19.11 Bid Size 100.00 Ask 21.87 Ask Size 200.00
Open 19.85 High 20.14 Low 19.62 Prev Close 19.89
Last Trade Volume 653,302 52 Wk Hi 48.41 52 Wk Low 19.08
Market Cap 1.5 bi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 74,550,111.00 EPS (TTM) -0.36 PE Ratio N/A Exchange NGS
  Last 3 Mo Last 12 Mo
Number of Insider Trades 20 84
Number of Buys 10 34
Number of Sells 10 50
Net Activity 0 393354
Last 10 Buys Shares
John T. Henderson 1,000
John T. Henderson 1,000
John T. Henderson 1,000
Mark Christopher Capone 1,000
Ralph L. Mcdade 1,000
John T. Henderson 1,000
Last 10 Sell Shares
Dennis H. Langer 1,000
Dennis H. Langer 1,000
Walter Gilbert 1,000
Dennis H. Langer 1,000
Dennis H. Langer 1,000
Walter Gilbert 1,000
Dennis H. Langer 1,000
Dennis H. Langer 1,000
Dennis H. Langer 1,000
Dennis H. Langer 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 45 45 45 45
Low Target Price Estimate 20 20 20 20
Mean Target Price Estimate 34 34 34 34
Standard Deviation 7.13 7.13 7.13 7.13
Date of Most Recent Estimate 06/04/18 05/14/18 05/14/18 06/04/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 3 3 3 3
Moderate Buy 0 0 0 0
Hold 7 7 8 8
Moderate Sell 1 1 1 1
Strong Sell 1 1 1 2
Mean Rec. 2.75 2.75 2.77 2.88